| Antifungal drugs: what brings the future? R Van Daele, I Spriet, J Wauters, J Maertens, T Mercier, S Van Hecke, ... Medical mycology 57 (Supplement_3), S328-S343, 2019 | 212 | 2019 |
| Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity L Vanderbeke, P Van Mol, Y Van Herck, F De Smet, S Humblet-Baron, ... Nature communications 12 (1), 4117, 2021 | 210 | 2021 |
| Phagosomal removal of fungal melanin reprograms macrophage metabolism to promote antifungal immunity SM Gonçalves, C Duarte-Oliveira, CF Campos, V Aimanianda, ... Nature communications 11 (1), 2282, 2020 | 86 | 2020 |
| Performance of existing definitions and tests for the diagnosis of invasive aspergillosis in critically ill, adult patients: a systematic review with qualitative evidence synthesis M Bassetti, DR Giacobbe, C Grecchi, C Rebuffi, V Zuccaro, L Scudeller, ... Journal of Infection 81 (1), 131-146, 2020 | 71 | 2020 |
| Galactomannan, a surrogate marker for outcome in invasive aspergillosis: finally coming of age T Mercier, E Guldentops, K Lagrou, J Maertens Frontiers in microbiology 9, 661, 2018 | 71 | 2018 |
| Lateral flow assays for diagnosing invasive pulmonary aspergillosis in adult hematology patients: a comparative multicenter study T Mercier, A Dunbar, E de Kort, A Schauwvlieghe, M Reynders, ... Medical mycology 58 (4), 444-452, 2020 | 67 | 2020 |
| Prevalence of voriconazole-resistant invasive aspergillosis and its impact on mortality in haematology patients A Resendiz-Sharpe, T Mercier, PPA Lestrade, MT van der Beek, ... Journal of Antimicrobial Chemotherapy 74 (9), 2759-2766, 2019 | 65 | 2019 |
| Defining galactomannan positivity in the updated EORTC/MSGERC consensus definitions of invasive fungal diseases T Mercier, E Castagnola, KA Marr, LJ Wheat, PE Verweij, JA Maertens Clinical Infectious Diseases 72 (Supplement_2), S89-S94, 2021 | 49 | 2021 |
| Serial detection of circulating mucorales DNA in invasive mucormycosis: a retrospective multicenter evaluation T Mercier, M Reynders, K Beuselinck, E Guldentops, J Maertens, ... Journal of Fungi 5 (4), 113, 2019 | 42 | 2019 |
| Successful allogenic stem cell transplantation in patients with inherited CARD9 deficiency F Queiroz-Telles, T Mercier, J Maertens, CBS Sola, C Bonfim, ... Journal of Clinical Immunology 39, 462-469, 2019 | 40 | 2019 |
| Beta-d-Glucan for Diagnosing Pneumocystis Pneumonia: a Direct Comparison between the Wako β-Glucan Assay and the Fungitell Assay T Mercier, E Guldentops, S Patteet, K Beuselinck, K Lagrou, J Maertens Journal of Clinical Microbiology 57 (6), 10.1128/jcm. 00322-19, 2019 | 36 | 2019 |
| Lung microbiota predict invasive pulmonary aspergillosis and its outcome in immunocompromised patients A Hérivaux, JR Willis, T Mercier, K Lagrou, SM Gonçalves, RA Gonçales, ... Thorax 77 (3), 283-291, 2022 | 32 | 2022 |
| Diagnosing invasive pulmonary aspergillosis in hematology patients: a retrospective multicenter evaluation of a novel lateral flow device T Mercier, A Schauwvlieghe, E de Kort, A Dunbar, M Reynders, ... Journal of Clinical Microbiology 57 (4), 10.1128/jcm. 01913-18, 2019 | 29 | 2019 |
| Prospective evaluation of the turbidimetric β-D-glucan assay and 2 lateral flow assays on serum in invasive aspergillosis T Mercier, E Guldentops, K Lagrou, J Maertens Clinical Infectious Diseases 72 (9), 1577-1584, 2021 | 28 | 2021 |
| Serum amyloid P component is an essential element of resistance against Aspergillus fumigatus A Doni, R Parente, I Laface, E Magrini, C Cunha, FS Colombo, ... Nature Communications 12 (1), 3739, 2021 | 27 | 2021 |
| Point of care aspergillus testing in intensive care patients T Mercier, A Dunbar, V Veldhuizen, M Holtappels, A Schauwvlieghe, ... Critical Care 24, 1-9, 2020 | 25 | 2020 |
| The Aspergillus Lateral Flow Assay for the Diagnosis of Invasive Aspergillosis: an Update JD Jenks, MH Miceli, J Prattes, T Mercier, M Hoenigl Current fungal infection reports 14, 378-383, 2020 | 23 | 2020 |
| Variable Correlation between Bronchoalveolar Lavage Fluid Fungal Load and Serum-(1,3)-β-d-Glucan in Patients with Pneumocystosis—A Multicenter ECMM … T Mercier, N Aissaoui, M Gits-Muselli, S Hamane, J Prattes, HH Kessler, ... Journal of Fungi 6 (4), 327, 2020 | 20 | 2020 |
| Immune parameters for diagnosis and treatment monitoring in invasive mold infection JD Jenks, SA Rawlings, C Garcia-Vidal, P Koehler, T Mercier, J Prattes, ... Journal of Fungi 5 (4), 116, 2019 | 18 | 2019 |
| Stopping antibiotic therapy after 72 h in patients with febrile neutropenia following intensive chemotherapy for AML/MDS (safe study): a retrospective comparative cohort study A Schauwvlieghe, A Dunbar, E Storme, A Vlak, R Aerts, J Maertens, ... EClinicalMedicine 35, 2021 | 15 | 2021 |
